Mittendorf EA, Zhang H, Barrios CH, Saji S, et al. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 Lancet 2020 Sep 18. pii: S0140-6736(20)31953.
PMID: 32966830